GlassScriptPhysician profile
Stephen H Bills
NPI 1780797464
$1,769.13
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $824 · 2021: $111 · 2023: $22.35 · 2024: $83.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $491.69 | 2019-2023 | |
| Amgen INC. | $317.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $177.71 | 2019-2024 | Xarelto |
| Pfizer INC. | $139.76 | 2019-2020 | |
| Glaxosmithkline, LLC. | $125.55 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $90.39 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $85.01 | 2019-2020 | |
| Allergan, INC. | $48.97 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $43.01 | 2019-2020 | |
| Lilly USA, LLC | $39.94 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.00 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.87 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $28.06 | 2019 | |
| Abbvie INC. | $19.16 | 2020 | |
| Daiichi Sankyo INC. | $17.37 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.82 | 2019 | |
| Djo, LLC | $15.36 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.32 | 2020 | |
| Esperion Therapeutics, INC. | $14.19 | 2020 | |
| Lundbeck LLC | $14.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Bills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.